PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX??? for the Prevention of Abdominal Colorectal Surgical Site Infections

Stock Information for PolyPid Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PolyPid Ltd.

PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
PolyPid to Participate in Citizens JMP Life Sciences Conference
PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
PolyPid Announces Private Placement for $16 Million in Gross Proceeds

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.